BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 29
• 30
• 31

• Press Releases

  Humacyte to Present at the Piper Sandler 36th Annual Healthcare Conference

  December 2, 2024

   · 

  2 min read
• Press Releases

  Ajax Therapeutics to Present Overview of Phase 1 Clinical Trial Evaluating AJ1‑11095, a First-in-Class Type II JAK2 inhibitor, for the Treatment of Myelofibrosis at the American Society of Hematology Annual Meeting

  December 2, 2024

   · 

  3 min read
• Press Releases

  CAMP4 to Participate in the Piper Sandler 36th Annual Healthcare Conference

  December 2, 2024

   · 

  6 min read
• Press Releases

  Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer

  December 2, 2024

   · 

  6 min read
• Press Releases

  CG Oncology to Host Conference Call and Webcast on BOND-003 Data on Thursday, December 5, 2024

  December 2, 2024

   · 

  4 min read
• Press Releases

  OncoC4 Announces FDA Clearance of IND Application for Potential Best-in-Class PD-1/VEGF Bispecific AI-081 in Advanced Solid Tumors

  December 2, 2024

   · 

  3 min read
• Press Releases

  Ovid Therapeutics to Present Multiple Posters Supporting Its Pipeline Programs Targeting Neuronal Hyperexcitability at the American Epilepsy Society 2024 Annual Meeting

  December 2, 2024

   · 

  5 min read
• Press Releases

  KisoJi Biotechnology Raises $41 Million to Advance Lead Program Into the Clinic and Deploy AI Tools Into Key Pipeline Indications

  December 2, 2024

   · 

  5 min read
• Press Releases

  MustGrow Biologics Signs Non-Binding Term-Sheet for Acquisition of NexusBioAg

  December 2, 2024

   · 

  8 min read
• Press Releases

  OSSIO Raises $27.6 Million to Accelerate Its Commercial Engine as High Demand for Bio-Integrative Fixation Technology Continues

  December 2, 2024

   · 

  4 min read